|
Tropical Journal of Pharmaceutical Research, Vol. 2, No. 2, Dec 2003, pp. 243-253 Leading Article Role of biotechnology in medicinal plants Leena Tripathi*, and Jaindra Nath Tripathi International Institute of Tropical Agriculture (IITA), Nigeria; C/o
L. W. Lambourn; Carolyn House, 26 Dingwall Rd, Croydon CR9 3EE, UK Code Number: pr03018 ABSTRACT Medicinal plants are the most important source of life saving drugs for the majority of the world’s population. The biotechnological tools are important to select, multiply and conserve the critical genotypes of medicinal plants. In-vitro regeneration holds tremendous potential for the production of high-quality plant-based medicine. Cryopreservation is long-term conservation method in liquid nitrogen and provides an opportunity for conservation of endangered medicinal plants. In-vitro production of secondary metabolites in plant cell suspension cultures has been reported from various medicinal plants. Bioreactors are the key step towards commercial production of secondary metabolites by plant biotechnology. Genetic transformation may be a powerful tool for enhancing the productivity of novel secondary metabolites; especially by Agrobacterium rhizogenes induced hairy roots. This article discusses the applications of biotechnology for regeneration and genetic transformation for enhancement of secondary metabolite production in-vitro from medicinal plants. Key words: Bioreactors; genetic transformation; regeneration; secondary metabolites Abbreviations: BA: 6-Benzylaminopurine; TDZ: 1-Phenyl-3-(1,2,3-thiadiazol-5-yl) urea; NAA: a -Naphthaleneacetic acid; IAA: Indole-3 acetic acid; 2iP: 6-(g -Dimethylallylamino) purine; 2,4-D: 2,4-Dichlorophenoxyacetic acid; GA3: Gibberellic acid INTRODUCTION Plants have been an important source of medicine for thousands of years. Even today, the World Health Organization estimates that up to 80 per cent of people still rely mainly on traditional remedies such as herbs for their medicines. Plants are also the source of many modern medicines. It is estimated that approximately one quarter of prescribed drugs contain plant extracts or active ingredients obtained from or modeled on plant substances. The most popular analgesic, aspirin, was originally derived from species of Salix and Spiraea and some of the most valuable anti-cancer agents such as paclitaxel and vinblastine are derived solely from plant sources1-3. Biotechnological tools are important for multiplication and genetic enhancement of the medicinal plants by adopting techniques such as in-vitro regeneration and genetic transformations. It can also be harnessed for production of secondary metabolites using plants as bioreactors. This paper reviews the achievements and advances in the application of tissue culture and genetic engineering for the in-vitro regeneration of medicinal plants from various explants and enhanced production of secondary metabolites. IN-VITRO REGENERATIONIn-vitro propagation of plants holds tremendous potential for the production of high-quality plant-based medicines4. This can be achieved through different methods including micropropagation. Micropropagation has many advantages over conventional methods of vegetative propagation, which suffer from several limitations5. With micropropagation, the multiplication rate is greatly increased. It also permits the production of pathogen-free material. Micropropagation of various plant species, including many medicinal plants, has been reported6-8. Propagation from existing meristems yields plants that are genetically identical with the donor plants9. Plant regeneration from shoot and stem meristems has yielded encouraging results in medicinal plants like Catharanthus roseus, Cinchona ledgeriana and Digitalis spp, Rehmannia glutinosa, Rauvolfia serpentina, Isoplexis canariensis 10-12. Numerous factors are reported to influence the success of in-vitro propagation of different medicinal plants9, 13-15. The effects of auxins and cytokinins on shoot multiplication of various medicinal plants have been reported. Benjamin et al. has shown that 6-Benzylaminopurine (BA), at high concentration (1–5ppm), stimulates the development of the axillary meristems and shoot tips of Atropa belladona 16 . Lal et al. observed a rapid proliferation rate in Picrorhiza kurroa using kinetin at 1.0–5.0 mg/l17. Direct plantlet regeneration from male inflorescences of medicinal yam on medium supplemented with 13.94 µM kinetin has also be reported18. The highest shoot multiplication of Nothapodytes foetida is achieved on medium containing thidiazuron (TDZ) at a concentration of 2.2 mM19. Similarly, it has been observed that cytokinin is required, in optimal quantity, for shoot proliferation in many genotypes but inclusion of low concentration of auxins along with cytokinin triggers the rate of shoot proliferation20-23. Barna and Wakhlu has indicated that the production of multiple shoots is higher in Plantago ovata on a medium having 4–6 M kinetin along with 0.05 µM NAA24. According to Faria and Illg, the addition of 10 µM BA along with 5 µM indole-3-acetic acid (IAA) or 5 µM NAA induces a high rate of shoot proliferation of Zingiber spectabile 25 . Faria and Illg have also shown that the number of shoots/explant depends on concentrations of the growth regulators and the particular genotypes. The nature and condition of explants has also been shown to have a significant influence on the multiplication rate of Clerodendrum colebrookianum by Mao et al.26. Actively growing materials were more responsive to shoot induction than dormant buds. Also BA was proved superior to 6-(g -Dimethylallylamino) purine (2ip) and TDZ for multiple shoot induction. CALLUS-MEDIATED ORGANOGENESIS The induction of callus growth and subsequent differentiation and organogenesis is accomplished by the differential application of growth regulators and the control of conditions in the culture medium. With the stimulus of endogenous growth substances or by addition of exogenous growth regulators to the nutrient medium, cell division, cell growth and tissue differentiation are induced. There are many reports on the regeneration of various medicinal plants via callus culture. Satheesh and Bhavanandan have reported the regeneration of shoots from callus of Plumbago rosea using appropriate concentrations of auxins and cytokinins27. Mantell and Hugo have also reported a high frequency of shoot, root, and microtuber production from Dioscorea alata depending on the culture medium used, the type of explant from which the calli originated, and the photoperiod28. Plant regeneration has been achieved from leaf callus of Cephaelis ipecacuanha on Murashige and Skoog medium supplemented with 4.5 mg/L kinetin and 0.1 mg/L α-Naphthaleneacetic acid (NAA)29. Ghosh and Sen established plant regeneration via callus cultures from different explants of Asparagus cooper 30 . The relative importance of genotype, explant and their interactions for in-vitro plant regeneration via organogenesis in Solanum melongena has been investigated31. Basu and Chand achieved shoot bud differenttiation from root-derived callus of Hyoscyamus muticus in MS medium supplemented with 0.05 mg/L NAA and 0.5 mg/L BA32. Saxena et al. reported plant regeneration via organogenesis from callus cultures derived from mature leaves, stems, petioles and roots of young seedlings of Psoralea corylifolia 33 . In-vitro organogenesis of Zingiber officinale via callus culture has been described by Rout and Das20. Further, Shasany et al. reported the influence of different growth regulators on high frequency plant regeneration from internodal explants of Mentha arvensis 22 . Successful plant regeneration was reported from stem and leaf-derived callus of Centella asiatica on MS medium supplemented with 4.0 mg/L BA, 2.0 mg/L kinetin, 0.25 mg/L NAA, and 20 mg/L adenine sulfate34. Rapid regeneration of Plumbago zeylanica in callus culture was achieved on MS medium supplemented with 2.0 mg/L BA and 0.5 mg/L IAA21. The efficient systems for in-vitro regeneration of Solanum laciniatum and Echinacea pallida have been established from leaf explants on medium supplemented with BA and NAA35, . Pande et al. have also reported the in-vitro regeneration of Lepidium sativum from various explants on medium supplemented with BA and NAA37. REGENERATION THROUGH SOMATIC EMBRYOGENESIS >Somatic embryogenesis is a process where groups of somatic cells/tissues lead to the formation of somatic embryos which resemble the zygotic embryos of intact seeds and can grow into seedlings on suitable medium. Plant regeneration via somatic embryogenesis from single cells, that can be induced to produce an embryo and then a complete plant, has been demonstrated in many medicinal plant species. Arumugam and Bhojwani noted the development of somatic embryos from zygotic embryos of Podophyllum hexandrum on MS medium containing 2 µM BA and 0.5 µM IAA32. Ghosh and Sen reported regeneration and somatic embryogenesis in Asparagus cooperi on MS medium having 1.0 mg/L NAA and 1.0 mg/L kinetin39. Embryogenic calluses and germination of somatic embryos in nine varieties of Medicago sativa has been achieved40. Using a medium containing 2,4-Dichlorophen-oxyacetic acid (2,4-D) and TDZ, Zhou et al. have achieved the induction of somatic embryogenesis in cells from Cayratia japonica 41. Somatic embryogenesis and subsequent plant regeneration from callus derived from immature cotyledons of Acacia catechu has also been achieved on medium supplemented with 13.9 µM kinetin and 2.7µM NAA42. Gastaldo et al. induced somatic embryogenesis from bark callus of Aesculus hippocastanum on MS medium supplemented with 2.0 mg/L kinetin, 2.0 mg/L 2,4-D and 2.0 mg/L NAA43. High-frequency somatic embryogenesis and plant regeneration from suspension cultures of Acanthopanax koreanum have been reported on a medium containing 4.5 µM 2,4-D44. Das et al. reported high frequency somatic embryogenesis in Typhonium trilobatum on medium containing 1.0 mg/L kinetin and 0.25 mg/L NAA45. The suspension culture of Catharanthus roseus from stem and leaf explants on medium containing NAA and kinetin has been established by Zhao et al.46. Chand and Sahrawat have reported the somatic embryogenesis of Psoralea corylifolia L. from root explants on medium supplemented with NAA and BA47. Efficient development and germination of somatic embryos are prerequisites for commercial plantlet production. Lowering of growth regulator concentrations in culture media has improved embryo development and germination of many medicinal plants38, 48, 49. Germination of the somatic embryos is achievable on MS medium without the growth regulator41, 44. However, Arumugam and Bhojwani noted that inclusion of BA (2 µM) and gibberellic acid (GA3, 2.8 µM) in the medium stimulated embryo development of Podophyllum hexandrum, although 75% of the embryos germinated on basal MS medium devoid of growth regulator38. Similar results were reported on the germination of embryos of Psoralea corylifolia 47. Wakhlu et al. have reported that the somatic embryos of Bunium persicum matured and germinated on the basal MS medium supplemented with 1.0 mg/L kinetin49. Further, Kunitake and Mii reported that 30–40% of somatic embryos of A. officinalis germinated after being treated with distilled water for a week; they were subsequently transferred to half-strength MS medium supplemented with 1.0 mg/L IAA, 1.0 mg/L GA3 and 1% sucrose50. However, the somatic embryos of Typhonium trilobatum have been germinated on MS medium supplemented with 0.01 mg/L NAA and 2% (w/v) sucrose after 2 weeks of culture45. CONSERVATION THROUGH CRYOPRESERVATIONThe cryopreservation of in-vitro cultures of medicinal plants is a useful technique. Cryopreservation is long-term conservation method in liquid nitrogen (–196 °C) in which cell division and metabolic and biochemical processes are arrested. A large number of cultured materials can be stored in liquid nitrogen51. Since whole plants can regenerate from frozen culture, cryopresevation provides an opportunity for conservation of endangered medicinal plants. For example, low temperature storage has been reported to be effective for cell cultures of medicinal and alkaloid-producing plants such as Rauvollfia serpentine, D. lanalta, A. belladonna, Hyoscyamus spp52. When plants are regenerated and no abnormality is seen either in fertility or in alkaloid content, the materials can be stored using cryopreservation methods. Cryopreservation has been used successfully to store a range of tissue types, including meristems, anthers/pollens, embryos, calli and even protoplasts. However, the system will depend on the availability of liquid nitrogen methods. PRODUCTION OF SECONDARY METABOLITES FROM MEDICINAL PLANTSPlants are the traditional source of many chemicals used as pharmaceuticals. Most valuable phytochemicals are products of plant secondary metabolism. The production of secondary metabolites in-vitro can be possible through plant cell culture53,54 . Successful establishment of cell lines capable of producing high yields of secondary compounds in cell suspension cultures has been reported by Zenk55. The accumulation of secondary products in plant cell cultures depends on the composition of the culture medium, and on environmental conditions56. Strategies for improving secondary products in suspension cultures, using different media for different species, have been reported by Robins57. The production of secondary metabolites in plant cell suspension cultures has been reported from various medicinal plants. The production of solasodine from calli of Solanum eleagnifolium, and pyrrolizidine alkaloids from root cultures of Senecio sp. are examples58, 59. Cephaelin and emetine were isolated from callus cultures of Cephaelis ipecacuanha 60. Scragg et al. isolated quinoline alkaloids in significant quantities from globular cell suspension cultures of Cinchona ledgeriana 61. Enhanced indole alkaloid biosynthesis in the suspension culture of Catharanthus roseus has also been reported46 . Ravishankar and Grewal reported that the influence of media constituents and nutrient stress influenced the production of diosgenin from callus cultures of Dioscorea deltoidea 62 . Parisi et al. obtained high yields of proteolytic enzymes from the callus tissue culture of garlic (Allium sativum L.) on MS medium supplemented with NAA and BAP63. Pradel et al. observed that the biosynthesis of cardenolides was maximal in the hairy root cultures of Digitalis lanata compared to leaf64. The production of azadirachtin and nimbin has been shown to be higher in cultured shoots and roots of Azadirachta indica compared to field grown plant65. Pande et al. reported that the yield of lepidine from Lepidium sativum Linn depends upon the source and type of explants37. Bioreactors are the key step towards commercial production of secondary metabolites by plant biotechnology. Bioreactors have several advantages for mass cultivation of plant cells: i. It gives better control for scale up of cell suspension cultures under defined
parameters for the production of bioactive compounds; Since the biosynthetic efficiency of populations varies, a high yielding variety should be selected as a starting material. The fundamental requirement in all this is a good yield of the compound, and reduced cost compared to the natural synthesis by the plants. The bioreactor system has been applied for embryogenic and organogenic cultures of several plant species66,67 . Significant amounts of sanguinarine were produced in cell suspension cultures of Papaver somniferum using bioreactors68. Ginseng root tissue cultures in a 20 tonne bioreactor produced 500 mg/L/day; of the saponin that is considered as a very good yield69. Jeong et al. have established the mass production of transformed Panax ginseng hairy roots in bioreactor70. Hahn et al. has observed the production of ginsenoside from adventitious root cultures of Panax ginseng through large-scale bioreactor system (1-10 ton)71. Bioreactors offer optimal conditions for large-scale plant production for commercial manufacture72. Much progress has been achieved in the recent past on optimization of these systems for the production and extraction of valuable medicinal plant ingredients such as ginsenosides and shikonin. Roots cultivated in bioreactors have been found to release medicinally active compounds, including the anticancer drug isolated from various Taxus species, into the liquid media of the bioreactor which may then be continuously extracted for pharmaceutical preparations4. Conventional practices require the harvest of the bark of trees, all approximately 100 years old, to obtain 1 kg of the active compound taxol73. Research over the last two decades has established efficient protocols for isolated cell cultures and a large-scale bioreactor system. The acceptance of this process for the industrial production of this invaluable compound has recently been established and will significantly impact the production of the tumor-inhibiting pharmaceutical73. GENETIC TRANSFORMATIONThe recent advances and developments in plant genetics and recombinant DNA technology have helped to improve and boost research into secondary metabolite biosynthesis. A major line of research has been to identify enzymes of a metabolic pathway and then manipulate these enzymes to provide better control of that pathway. Transformation is currently used for genetic manipulation of more than 120 species of at least 35 families, including the major economic crops, vegetables, ornamental, medicinal, fruit, tree and pasture plants, using Agrobacteriummediated or direct transformation methods74. However, Agrobacterium-mediated transformation offers several advantages over direct gene transfer methodologies (particle bombardment, electroporation, etc), such as the possibility to transfer only one or few copies of DNA fragments carrying the genes of interest at higher efficiencies with lower cost and the transfer of very large DNA fragments with minimal rearrangement75-77. The gram-negative soil bacteria, Agrobacterium tumefaciens, and the related species, A. rhizogenes, are causal agents of the plant diseases crown gall tumour and hairy root, respectively. These species, which belong to the Rhizobiaceae, are natural engineers that are able to transform or modify, mainly dicotyledonous plants, although there are reports on the infection of monocotyledonous plants78-80. Virulent strains of A. tumefaciens and A. rhizogenes contain a large megaplasmid (more than 200 kb) which play a key role in tumor induction and for this reason it was named Ti plasmid, or Ri in the case of A. rhizogenes. During infection the T-DNA, a mobile segment of Ti or Ri plasmid, is transferred to the plant cell nucleus and integrated into the plant chromosome. Agrobacterium tumefaciens transfers the T-DNA into the nucleus of infected cells where it is then stably integrated into the host genome and transcribed, causing the crown gall disease81, 82. T-DNA contains two types of genes: the oncogenic genes, encoding for enzymes involved in the synthesis of auxins and cytokinins and responsible for tumor formation; and the genes encoding for the synthesis of opines. Agrobacterium rhizogenes has been used regularly for gene transfer in many dicotyledonous plants78. Plant infection with this bacterium induces the formation of proliferative multibranched adventitious roots at the site of infection; the so-called ‘hairy roots’83. This infection is followed by the transfer of a portion of DNA i.e. T-DNA, known as the root inducing plasmid (Ri-plasmid), to the plant cell chromosomal DNA. The research is going for the application of plant transformation and genetic modification using A. rhizogenes, in order to boost production of those secondary metabolites, which are naturally synthesized in the roots of the mother plant. Transformed hairy roots mimic the biochemical machinery present and active in the normal roots, and in many instances transformed hairy roots display higher product yields. Genetic transformation has been reported for various medicinal plants. Naina et al. reported the successful regeneration of transgenic neem plants (Azadirachta indica) using Agrobacterium tumefaciens containing a recombinant derivative of the plasmid pTi 84. The genetic transformation of Atropa belladona has been reported using Agrobacterium tumefaciens, with an improved alkaloid composition85,86. Agro-bacterium mediated transformation of Echinacea purpurea has been demonstrated using leaf explants87. Genetic transformation would be a powerful tool for enhancing the productivity of novel secondary metabolites of limited yield. Hairy roots, transformed with Agrobacterium rhizogenes, have been found to be suitable for the production of secondary metabolites because of their stable and high productivity in hormone-free culture conditions. A number of plant species including many medicinal plants have been successfully transformed with Agrobacterium rhizogenes. The hairy root culture system of the medical plant Artemisia annua L. was established by infection with Agrobacterium rhizogenes and the optimum concentration of artimisin was 4.8 mg/L88. Giri et al. induced the development of hairy roots in Aconitum heterophyllum using Agrobacterium rhizogenes 89 . Pradel et al. developed a system for producing transformed plants from root explants of Digitalis lanata 64 . They evaluated different wild strains of Agrobacterium rhizogenes for the productions of secondary products obtained from hairy roots and transgenic plants. They reported higher amounts of anthraquinones and flavonoids in the transformed hairy roots than in untransformed roots. An efficient protocol for the development of transgenic opium poppy (Papaver somniferum L.) and California poppy (Eschscholzia californica Cham.) root cultures using Agrobacterium rhizogenes is reported90. Bonhomme et al. has reported the tropane alkaloid production by hairy roots of Atropa belladonna obtained after transformation with Agrobacterium rhizogenes 91. Argolo et al. reported the regulation of solasodine production by Agrobacterium rhizogenes-transformed roots of Solanum aviculare 92. Souret et al. have demonstrated that the transformed roots of A. annua are superior to whole plants in terms of yield of the sesquiterpene artemisinin93. Shi and Kintzios have reported the genetic transformation of Pueraria phaseoloides with Agrobacterium rhizogenes and puerarin production in hairy roots94 . The content of puerarin in hairy roots reached a level of 1.2 mg/g dry weight and was 1.067 times the content in the roots of untransformed plants. Thus, these transformed hairy roots have great potential as a commercially viable source of secondary metabolites. CONCLUSION Plants have been an important source of medicine for thousands of years. Medicines in common use, such as aspirin and digitalis, are derived from plants, and new transgenic varieties could be created as efficient green production lines for other pharmaceuticals as well as vaccines and anticancer drugs. Tissue culture is useful for multiplying and conserving the species, which are difficult to regenerate by conventional methods and save them from extinction. The production of secondary metabolites can be enhanced using bioreactors. Bioreactors offer a great hope for the large-scale synthesis of therapeutically active compounds in medicinal plants. Since the biosynthetic efficiency of populations varies, a high yielding variety is recommended as a starting material. Genetic transformation may provide increased and efficient system for in-vitro production of secondary metabolites. The improved in-vitro plant cell culture systems have potential for commercial exploitation of secondary metabolites. Tissue culture protocols have been developed for several plants but there are many other species, which are over exploited in pharmaceutical industries and need conservation. REFERENCES
Copyright @2002-2004. TJPR Faculty of Pharmacy, University of Benin, Benin City, Nigeria |
|